The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity

NCT02689999 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG: Dexrabeprazole 10 mg Enteric-Coated Tablets

Sponsor

Neutec Ar-Ge San ve Tic A.Ş